Administration d'anticorps anti-CD3 dans le traitement de maladies auto-immunes

• 收藏
• 分享

专利权人:

Tolerrx Inc.

发明人:

申请号：

EP11190677.2

公开号：

EP2433650A3

申请日:

2007.06.05

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

A method of treating an autoimmune disease, such as, diabetes or psoriasis, by administering an anti-CD3 antibody, or anti-CD3 antibody fragment. The anti-CD3 antibody, or anti-CD3 antibody fragment, is administered over a course of treatment wherein, during the course of treatment, the anti-CD3 antibody, or anti-CD3 antibody fragment is administered in a total amount which does not exceed 300 µg/kg when administered intravenously or, when administered other than intravenously, is administered in a total amount that does not exceed a total amount bioequivalent to 300µg/kg of intravenous administration thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/